Long-term association of cardiovascular risk factors with impaired insulin secretion and insulin resistance

Metabolism: Clinical and Experimental

Volumn 49, Issue 10, 2000, Pages 1247-1254

  Kekalainen, P ^a   Sarlund, H ^a   Laakso, M ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; URIC ACID; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; DYSLIPIDEMIA; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 0033794248     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2000.9514     Document Type: Article

References (43)

1. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations
2. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: Paris Prospective Study, 15-year follow-up
3. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men. The 22-year follow-up results of the Helsinki Policemen Study
4. Insulin resistance, glucose intolerance, hyperinsulinemia and dyslipidemia in patients with angio-graphically demonstrated coronary artery disease
5. Role of insulin resistance in human disease
6. Insulin resistance and risk factors for coronary heart disease
7. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: Prospective studies of Pima Indians
8. Relationship between lipoprotein levels and in vivo insulin action in normal young white men
9. Influence of insulin resistance, secretion, and clearance on serum cholesterol, triglycerides, lipoprotein cholesterol, and blood pressure in healthy men
10. Isolated low HDL cholesterol. And insulin-resistant state
11. Is there a sex difference in the association of plasma insulin level and insulin sensitivity with serum lipids and lipoproteins?
12. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles
13. Prospective analysis of the insulin-resistance syndrome (syndrome X)
14. Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects
15. Cardiovascular risk factors and hyperinsulinemia in elderly men: The Honolulu Heart Program
16. Insulin resistance in essential hypertension
17. Determinants of insulin sensitivity and consequences for lipoproteins and blood pressure in subjects with non-insulin dependent diabetes mellitus
18. Racial differences in the relation between blood pressure and insulin resistance
19. Insulin sensitivity index, acute insulin response and glucose effectiveness in a population-based sample of 380 young healthy Caucasians
20. Blood pressure, insulin secretion and resistance in nonhypertensive and hypertensive obese female subjects
21. Reduced insulin secretion: An independent predictor of body weight gain
22. Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity. 5-year follow-up among initially nondiabetic Japanese-American men
23. Familial aggregation of non-insulin dependent diabetes and coronary heart disease are accompanied by different effects on serum lipids, lipoproteins and apolipoproteins
24. Diabetes mellitus. Report of WHO Study Group
25. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects
26. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model
27. Quantitative estimation of insulin sensitivity
28. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance
29. Insulin resistance versus insulin secretion in the hypertension of obesity
30. Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglycerides
31. Relation of fasting plasma insulin concentration to high density lipoprotein cholesterol and triglyceride concentrations in men
32. Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men
33. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance
34. Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population
35. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations
36. Insulin sensitivity, lipids and body composition in childhood: Is 'syndrome X' present?
37. Essential hypertension is associated with decreased insulin clearance and insulin resistance
38. Essential hypertension and insulin resistance in non-insulin-dependent diabetes
39. The relation between serum insulin levels and 8-year changes in lipid, lipoprotein and blood pressure levels
40. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration
41. Hyperuricemia and insulin resistance
42. Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential
43. Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia